Treatment for Non-Hodgkin's Lymphoma

Phase-Based Progress Estimates
Mayo Clinic Jacksonville, Jacksonville, FLNon-Hodgkin's Lymphoma+1 More
All Sexes
What conditions do you have?

Study Summary

This trial will test an allogeneic cryopreserved NK cell therapy derived from donor peripheral blood, in combination with rituximab, for patients with relapsed or refractory B Cell non-Hodgkin lymphoma.

Eligible Conditions
  • Non-Hodgkin Lymphoma
  • Non-Hodgkin's Lymphoma

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: up to 1 year

Day 28
Phase 1: Safety as determined by dose limiting toxicities (DLTs)
up to 1 year
Phase 2: overall response rate

Trial Safety

Trial Design

0 Treatment Group

99 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 1 & 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 year

Who is running the clinical trial?

Gamida Cell ltdLead Sponsor
8 Previous Clinical Trials
300 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have already received CAR-T cell therapy or your doctor has determined that CAR-T therapy is not suitable for you.

Frequently Asked Questions

How many participants are engaged in this trial?

"To adequately conduct this research, Gamida Cell Ltd needs 99 participants who comply with the selection criteria. The trial will be run at Loyola University, Cardinal Bernardin Cancer Center in Maywood, Illinois and Dana-Farber/Mass General Brigham Cancer Care, Inc. in Boston, Massachusetts respectively." - Anonymous Online Contributor

Unverified Answer

How many healthcare facilities are participating in this trial?

"At present, there are 4 trial sites hosting this medical study. Two of the locations are in Maywood and Boston while Detroit is another option. Additionally, there exist other centres nearby to reduce travelling if you choose to participate." - Anonymous Online Contributor

Unverified Answer

Is enrollment for this trial still open to participants?

"As of the August 15th update, this clinical trial is still actively looking for participants. The original post was made to on July 5th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.